Please ensure JavaScript is enabled for purposes of website accessibility Virtual Events | KRYSTEXXA® (pegloticase)

KRYSTEXXA is a prescription medicine used in adults to help reduce the signs and symptoms of gout that are not controlled by other treatments. Read More

You are not alone on this journey. Hearing from real patients who have faced similar challenges can be incredibly reassuring and informative. Empower yourself and join our Gout Talk webinar to learn from gout specialists and real patients who have been where you are now and gain valuable insights for your next steps. Mark your calendar for a 1-hour conversation via Zoom with a gout specialist and a KRYSTEXXA patient. Join from your computer or phone.

Featured Events

Join

Dr. Julia Buchfuhrer, D.O., and Michael

Join

Dr. Julia Buchfuhrer, D.O., and

Michael


Join us for a live, online discussion about
uncontrolled gout and KRYSTEXXA
  • Dr. Julia Buchfuhrer, D.O.
    Gout Specialist
  • Michael
    Gout Patient
  • Wednesday, March 4
  • 7 PM ET
  • Online (Zoom)
  • Register Now

Join

Dr. Julia Buchfuhrer, D.O., and Michael

Join

Dr. Julia Buchfuhrer, D.O., and

Michael


Join us for a live, online discussion about
uncontrolled gout and KRYSTEXXA
  • Dr. Julia Buchfuhrer, D.O.
    Gout Specialist
  • Michael
    Gout Patient
  • Wednesday, April 15
  • 7 PM ET
  • Online (Zoom)
  • Register Now

Join

Dr. Julia Buchfuhrer, D.O., and Michael

Join

Dr. Julia Buchfuhrer, D.O., and

Michael


Join us for a live, online discussion about
uncontrolled gout and KRYSTEXXA
  • Dr. Julia Buchfuhrer, D.O.
    Gout Specialist
  • Michael
    Gout Patient
  • Wednesday, May 13
  • 7 PM ET
  • Online (Zoom)
  • Register Now

Watch patient stories

A Gout Talk virtual event is coming your way soon. In the meantime, check out our videos of patients taking back control of gout. Jen described her intense pain from gout as “bone crushing.” She tried several oral medicines, but nothing helped. Fortunately, visiting a gout specialist led her to KRYSTEXXA, an effective treatment for uncontrolled gout.

  • Read transcript

    Narrator:

    KRYSTEXXA® (pegloticase) is a prescription medicine for adults who have tried other gout medicines and still have high uric acid and gout symptoms. KRYSTEXXA is not recommended if you have high levels of uric acid without a history of gout. Serious allergic reactions may happen in some patients who receive KRYSTEXXA. These allergic reactions can be life-threatening and usually happen within 2 hours of the infusion. Please listen to the Important Safety Information in this video.

    Jen:

    The gout pain was severe. It is unlike anything else I'd ever experienced, and it's literally like a band is just wrapped around your entire foot and is just tightening and tightening and tightening, and it feels like it's bone crushing. This pain impacted my life because just moving around is intense pain and you can't do anything. When nothing was working, I was really thinking, "This is my life. We know what it is, and I've been given medication for it, and it's not working, so what else is there to do at that point?” I was terrified. I can't live like this. I was kind of like, "Okay, I'll go see a new doctor, and he's a gout specialist. That's great. Maybe he can tell me a little bit more." He did mention KRYSTEXXA. This is an infusion drug, and it's a big-time commitment.

Get support for your gout journey

Sign up for emails with helpful info about uncontrolled gout, KRYSTEXXA, and tips to help you feel prepared every step of the way.

USE AND IMPORTANT SAFETY INFORMATION

What is the most important information I should know about KRYSTEXXA® (pegloticase)?

Serious allergic reactions may happen in some patients who receive KRYSTEXXA. These allergic reactions can be life-threatening and usually happen within 2 hours of the infusion.

KRYSTEXXA should be given to you by a doctor or nurse in a healthcare setting where serious allergic reactions can be treated. Your doctor or nurse should watch you for any signs of a serious allergic reaction during and after your treatment with KRYSTEXXA.

Tell your doctor or nurse right away if you have any of these symptoms during or after your treatment with KRYSTEXXA:

  • wheezing, shortness of breath, cough, chest tightness, chest pain, or trouble breathing
  • dizziness, fainting, fast or weak heartbeat or feeling nervous
  • reddening of the face, itching, hives, or feeling warm
  • swelling of the throat or tongue, throat tightness, hoarse voice, or trouble swallowing

Who should not receive KRYSTEXXA?

Do not receive KRYSTEXXA if you:

  • have a rare blood problem called glucose-6-phosphate dehydrogenase (G6PD) deficiency or favism. Your doctor may test you for G6PD before you start KRYSTEXXA.
  • have had a serious allergic reaction to KRYSTEXXA or any of its ingredients. See the end of the Medication Guide for a complete list of ingredients in KRYSTEXXA.

What should I tell my doctor before receiving treatment with KRYSTEXXA?

Before you receive KRYSTEXXA, tell your doctor about all of your medical conditions, including if you:

  • ever had any heart problems or high blood pressure.
  • are pregnant or plan to become pregnant. It is not known if KRYSTEXXA will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed. It is not known if KRYSTEXXA passes into your breast milk. You and your doctor should decide if you will receive KRYSTEXXA or breastfeed.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Do not take any other uric acid lowering drug, such as allopurinol, febuxostat (Uloric), or probenecid, while receiving KRYSTEXXA.

KRYSTEXXA is recommended to be given with another prescription medicine called methotrexate. KRYSTEXXA may also be used alone. You and your doctor will decide the treatment that is right for you.

Prior to your treatment with KRYSTEXXA, your doctor may give you medicine to help reduce your risk of getting gout flares or an allergic reaction. Take these medicines as directed by your doctor or nurse. Your doctor will also test your uric acid levels prior to each treatment to monitor your response to KRYSTEXXA.

Your gout flares may increase in the first 3 months when you start receiving KRYSTEXXA. It’s important to understand that this is happening because KRYSTEXXA is breaking down uric acid in your body. Do not stop receiving KRYSTEXXA even if you have a flare, as the amount of flares will decrease after 3 months of treatment. Your doctor may give you other medicines to help reduce your gout flares for the first few months after starting KRYSTEXXA.

What are the possible side effects of KRYSTEXXA?

In KRYSTEXXA clinical trials:
The most common side effects of KRYSTEXXA when given together with methotrexate were
gout flares, joint pain, coronavirus disease 2019 (COVID-19), nausea, and fatigue.
The most common side effects of KRYSTEXXA were gout flares, allergic reactions (including infusion reactions). See “What is the most important information I should know about KRYSTEXXA?”, nausea, bruising, sore throat, constipation, chest pain, coronavirus disease 2019 (COVID-19), and vomiting.
This is not a complete list of all possible side effects. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/safety/medwatch or call 1-800-FDA-1088.

For additional Important Safety Information, please see the Full Prescribing Information, including Boxed Warning and Medication Guide and discuss with your doctor.

USE

KRYSTEXXA is a prescription medicine used in adults to help reduce the signs and symptoms of gout that are not controlled by other treatments.

KRYSTEXXA is not for use in people with too much uric acid in their bodies who do not have symptoms (asymptomatic hyperuricemia).

USE AND IMPORTANT SAFETY INFORMATION

What is the most important information I should know about KRYSTEXXA® (pegloticase)?

Serious allergic reactions may happen in some patients who receive KRYSTEXXA. These allergic reactions can be life-threatening and usually happen within 2 hours of the infusion.